RENJI Novel Coronavirus (COVID-19) Nucleic Acid Detection Kit (Real-time RT-PCR Method) - Indonesia BPOM Medical Device Registration
RENJI Novel Coronavirus (COVID-19) Nucleic Acid Detection Kit (Real-time RT-PCR Method) is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20303321184. The device is manufactured by CHANGSHA RENJI MEDICAL EQUIPMENT CO.,LTD. from China, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is PT. JUOSPUR MULTI PELITA.
This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.
Risk Classification
Product Class
Kelas : 2
Manufacturer
CHANGSHA RENJI MEDICAL EQUIPMENT CO.,LTD.Country of Origin
China
Authorized Representative
PT. JUOSPUR MULTI PELITAAR Address
JUOSPUR MULTI PELITA
Registration Date
Jun 06, 2023
Expiry Date
Nov 14, 2026
Product Type
Serological Reagents
Respiratory viral panel multiplex nucleic acid assay
Invitro Diagnostics
JUOSPUR Disposable Virus Specimen Collection Tube
CHANGSHA RENJI MEDICAL EQUIPMENT CO.,LTD.
JUOSPUR Disposable Virus Specimen Collection Tube
CHANGSA RENJI MEDICAL EQUIPMENT CO., LTD
JUOSPUR Disposable Virus Specimen Collection Tube
SHANDONG CHENGWU MEDICAL PRODUCTS FACTORY

